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ABSTRACT
Objectives: This study is aimed to evaluate the role of maternal mean platelet volume (MPV) levels for antenatal prediction 
marker of early onset neonatal sepsis in term infants born to mothers who have low infection risk.
Material and methods: A total of 62 pregnant women who gave birth in our hospital and whose neonates were admitted 
to a third level Neonatal Intensive Care Unit due to confirmed neonatal sepsis between January 2010 and May 2016 were 
selected as a study group. Within the same period, 68 women who gave birth to healthy neonates were enrolled as a con-
trol group. We compared maternal MPV values which were evaluated before delivery. The receiver operating characteristic 
(ROC) curves were drawn to evaluate the values maternal MPV in the diagnosis of neonatal sepsis. 
Results: MPV levels were detected statistically higher in the study group than the control group (8.27 ± 1.85 vs. 8.98 ± 1.16) 
(p = 0.001).
Conclusion: The maternal serum MPV level is a clinically useful, non-invasive and reliable marker in antenatal prediction 
of EOS. 
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INTRODUCTION
Early onset neonatal sepsis (EOS) is a systemic inflam-
matory response syndrome occurring within 72 hours of 
birth [1]. Although lots of diagnostic measures and treat-
ment approaches are available in developing countries, the 
incidence of EOS varies from 10 to 20/1000 live births and ap-
proximately 1% of infants die due to sepsis related causes [2].
Apnea, hypothermia, tachypnea, grunting, lethargy, and 
vomiting of an infant may put the clinician into doubt about 
EOS. These findings may often mixable with noninfective 
causes because they are not specific for EOS [3]. Verifica-
tion of EOS is also important to avoid overtreatment of 
non-septic infants with antimicrobial agents which may 
cause to colonization with drug-resistant microorganisms 
and superinfection with other pathogens. At this point se-
rum biomarkers have been proposed as being useful indica-
tors for early identification of septic infants [4].
Many biomarkers have been reported to be valuable to 
predict the disease before clinical manifestations occuring 
in the literature [5–7]. But the common characteristics of 
these studies are either that they have examined the infants 
of high-risk mothers or have examined infants with suspi-
cious clinical findings. In the recent literature there is no 
study evaluating maternal serum biomarkers to predict early 
neonatal sepsis in low risk mothers before the baby is born.
The objective of this study was to predict EOS in infants 
born to mothers who had low risk of infection. It is easy to 
predict the disease of infants born to mothers who had clini-
cal findings of suspected or overt chorioamnionitis and any 
other signs of systemic infection, but neonatal sepsis may 
develop without any kind of maternal infection exist. Sub-
clinical intrauterine infection has been implicated as a ma-
jor etiological factor in the pathogenesis and subsequent 
morbidity associated with EOS developed due to preterm 
membrane rupture, but EOS can also be developed in infants 
born to mothers who had no risk factor of infection [8]. 
Due to the reason mentioned above, we aimed to evalu-
ate the role of maternal mean platelet volume (MPV) levels 
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for antenatal prediction marker of EOS in term infants born 
to mothers who have low infection risk.
MATERIAL AND METHODS
Study population
This retrospective observational study was performed in 
a tertiary referral hospital between January 2010 and May 
2016 in İstanbul, Turkey. The institutional Ethics Committee 
approved the study protocol. Written informed consent was 
obtained from a parent or guardian of each infant. Women 
included in this study were divided into two groups as sepsis 
(n = 62) and control (n = 68) according to whether their 
babies have taken EOS diagnosis. Babies suspected as EOS 
were admitted to our third level Neonatal Intensive Care 
Unit (NICU) and EOS were confirmed by the findings of 
blood and/or cerebrospinal fluid culture growing bacteria 
in NICU. The decision to obtain blood or cerebrospinal fluid 
for culture was at the discretion of the NICU clinicians.
Women with suspected or proven choriamnionitis clini-
cal findings, any proven systemic infection and inflamma-
tion (either with higher WBC, CRP levels, fever or any other 
symptom of infection), preterm membrane ruptures, ane-
mia, trombositopenia, platelet transfusion history, diabetes 
mellitus were excluded.
Blood samples
Five ml of venous blood was obtained from all participants 
at admission before any medication and IV fluid infusion per-
formed. Only the blood samples taken no more than 5 hours 
prior to delivery were evaluated. MPV determinations were 
performed on the Coulter Counter model LH (Coulter Elec-
tronics, Hialeah, FL, USA). EOS diagnosis and follow-up of 
infants were done in our NICU unit by neaonatologist. 
Statistical analysis
The statistical analyses were performed by using the 
Statistic Package for Social Sciences (ver. 12.0; SPSS Inc., 
Chicago, USA). Categorical variables were compared by 
Chi square test. Non-categorical variables were compared 
by Mann-Whitney test. The p value < 0.05 was accepted as 
statistically significant. ROC analysis was used to calculate 
a cut off value.
RESULTS
A total of 130 term singleton pregnant women were 
included in this study. The demographic characteristics 
were shown in Table 1. There was no difference between 
control and study groups in terms of mean maternal age 
(27 ± 2 vs. 28 ± 1.1), mean gestational weeks at admis-
sion (39.26 ± 1.15 vs. 39.34 ± 2.04) and mean birth weights 
(3450 ± 290 vs. 3380 ± 310). The groups were identical 
regarding the mode of delivery (p = 0.825). 
Comparison of the MPV and white blood cells (WBC) 
levels of the groups were reported in Figure1. There was no 
difference regarding WBC levels among groups (p = 0.12). 
MPV levels were detected statistically higher in study group 
than control group. (8.27 ± 1.85 vs. 8.98 ± 1.16; p = 0.001) 
(Table 2).
None of the participants were thrombocytopenic but 
in comparison with the control group, platelet counts were 
lower in study group (264 ± 25 vs. 210 ± 30; p = 0.04) (Table 2).
Table 1. The demographic characteristics of groups
Control  
(n = 68)
EOS  
(n = 62) P
Age 27 ± 2 28 ± 1.1 0.628 
Gravidity 
Median (IQR) 1 (2) 1 (1) 0.320
 
Parity 
Median (IQR) 1 (2) 1 (1) 0.21
Gestational weeks 
Mean ± SD 39.26 ± 1.15 39.34 ± 2.04 0.788
 
Delivery mode n (%)
vaginal
cesarean section
 
100 (56.2%)
78 (43.8%)
 
27 (57.4%)
20 (42.6%)
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Figure 1. ROC diagram of MPV values
Table 2. The comparison of WBC, platelet count and MPV levels 
of groups
Control  
(n = 68)
EOS  
(n = 62) P
WBC 
Mean ± SD 27 ± 2 28 ± 1.1 0.628 
MPV 
Mean ± SD 8.27 ± 1.85 8.98 ± 1.16 0.001
Platelet count 
Mean ± SD 264 ± 25 210 ± 30 0.04
314
Ginekologia Polska 2017, vol. 88, no. 6
www. journals.viamedica.pl/ginekologia_polska
ROC analysis was used to calculate a cut off value but 
a significant cut off value was not found (AUC = 0.65) (Fig. 1).
DISCUSSION
Early onset neonatal sepsis, mostly remarkable in the 
developing countries, is a major cause of morbidity and 
mortality of infants [1]. Early diagnosis and adequate theory 
of the infected neonates play a vital role in lowering such 
mortality and morbidity rates [4]. The best known risk fac-
tors for EOS are chorioamnionitis and maternal systemic 
infections. Preterm birth and preterm rupture of membranes 
are also other risk factors for chorioamnionitis and EOS [9].
Simple, rapid, non invasive, and safe intrauterine infec-
tion detection tests can be useful in prediction of neona-
tal infection of babies of mothers either with or without 
active labor. If maternal infections during pregnancy are 
diagnosed and treated early, the mortality and morbidity 
of neonates due to EOS can be decreased. In the literature, 
several diagnostic methods of peripartum intrauterine infec-
tion detection have been considered. These can be listed as 
amniotic fluid cultures, serum procalcitonin, C-reactive pro-
tein (CRP) interleukin (IL)-6, IL-8, IL-10, IL-18, tumor necrosis 
factor-alpha (TNF-alpha), interferon gamma levels etc. [10].
In all the studies we mentioned above, the authors 
aimed to diagnose the intrauterine infections of mothers 
who were in high risk for peripartum infections. The first 
difference of the present study was that we aimed to pre-
dict the EOS in women who were in low risk for peripartum 
infections. The second difference was that only term infants 
were included. Since the prematurity, preterm rupture of 
membranes and proven or suspected intrauterine infections 
are risk factors for EOS, we think that our strict inclusion and 
exclusion criterias are valuable in terms of the reliability of 
the prediction of EOS with maternal MPV levels. Due to the 
reasons mentioned above, even they have healthy babies, 
higher maternal MPV levels can be seen in those women 
excluded from the study. 
In this study we selected the maternal MPV as a predic-
tor of EOS asMPV is considered to be a marker of platelet 
production, consumption and severity of some diseases 
associated with bone marrow, hypoxia, perinatal inflam-
mation and infections [11]. To our knowledge, the study is 
the first to report the high maternal MPV levels as a useful 
predictive marker of EOS diagnosis in term neonates born 
to mothers with low infection risk.
In concordance with our results there are studies reporting 
that high fetal MPV levels may predict the EOS in preterm in-
fants [12, 13]. These results are also valuable for early diagnosis 
of the disease of the neonates. The superiority of the present 
study is that it allows to predict the diagnosis of EOS before 
birth even in neonates born to women with low infection risk.
As a limitation of this study we did not analyze multi 
variation and demonstration of MPV as an independent 
risk factor for sepsis diagnosis. Another limitation was 
a  small number of patients. Further analyses are needed to 
determine a cut-off value for MPV in such women with term 
singleton pregnancies.
In conclusion, analysis of maternal MPV is a simple labo-
ratory investigation. In this study we found that mothers of 
term infants with EOS had higher maternal MPV levels before 
delivery. This might be associated with inflammatory and 
oxidative process.
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